Protein kinase inhibitors for amyotrophic lateral sclerosis therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Protein kinase inhibitors for amyotrophic lateral sclerosis therapy

Published:2020-08-31 Issue:6 Volume:178 Page:1316-1335
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Palomo Valle¹²^ORCID,Nozal Vanesa¹^ORCID,Rojas‐Prats Elisa¹^ORCID,Gil Carmen¹²^ORCID,Martinez Ana¹²^ORCID

Affiliation:

1. Centro de Investigaciones Biológicas‐CSIC Madrid Spain

2. Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED) Instituto Carlos III Madrid Spain

Funder

Comunidad de Madrid

Ministerio de Educación, Cultura y Deporte

Instituto de Salud Carlos III

Federación Española de Enfermedades Raras

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15221

Reference153 articles.

1. p38α stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis

2. Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

3. The neuroprotective effect of the GSK-3β inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice

4. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Nuclear hormone receptors

5. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adenine, a key player in biology and medicinal chemistry;Comptes Rendus. Chimie;2024-07-11

2. Allosteric modulation of protein kinase A in individuals affected by NLPD-PKA, a neurodegenerative disease in which the RIβ-L50R variant is expressed;2024-07-01

3. Designing multitarget ligands for neurodegenerative diseases with improved permeability trough PLGA nanoencapsulation;Biomedicine & Pharmacotherapy;2024-06

4. Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer;BMC Medicine;2024-02-19

5. Drug Screening and Validation Targeting TDP-43 Proteinopathy for Amyotrophic Lateral Sclerosis;Aging and disease;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3